(Q35850684)

10 August 2017

1 reference

title

Clinical proteomics: Applications for prostate cancer biomarker discovery and detection (English)

1 reference

10 August 2017

0 references

1 reference

3

Lance A Liotta

1 reference

10 August 2017

Emanuel F Petricoin

1

1 reference

10 August 2017

David K Ornstein

series ordinal

2

1 reference

10 August 2017

publication date

1 July 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

22

1 reference

10 August 2017

issue

4

1 reference

10 August 2017

page(s)

322-328

1 reference

The human plasma proteome: history, character, and diagnostic prospects

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.011

Identification of needs in biomarker research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.011

Characterization of the low molecular weight human serum proteome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.011

Comprehensive phenotyping and biological marker discovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.011

Shotgun proteomics and biomarker discovery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.011

Renal processing of low molecular weight proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.011

Renal handling of low molecular weight proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.011

Clinical proteomics: Written in blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.011

Biomarker amplification by serum carrier protein binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.011

Use of proteomic patterns in serum to identify ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.011

Serum proteomic patterns for detection of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.011

Cancer diagnosis using proteomic patterns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.011

Counterpoint: The vision for a new diagnostic paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.011

Mass spectrometry-based diagnostics: the upcoming revolution in disease detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.011

Proteomic patterns of tumour subsets in non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.011

Toxicoproteomics: serum proteomic pattern diagnostics for early detection of drug induced cardiac toxicities and cardioprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.011

Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.011

Detection of cancer-specific markers amid massive mass spectral data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.011

High-resolution serum proteomic features for ovarian cancer detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.011

Prostate-specific antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.011

Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.011

Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.011

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.011

Complexed Prostate Specific Antigen Improves Specificity for Prostate Cancer Detection: Results of a Prospective Multicenter Clinical Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.011

Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.011

An investigation into the human serum "interactome"

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.011

10.1016/J.UROLONC.2004.04.011

7 January 2021

Identifiers

DOI

1 reference

10 August 2017

1 reference